Jannik N. Andersen
- Immunology top 2%
- Galectins and Cancer Biology 11
- interferon and immune responses 4
- Toxicology top 1%
- Molecular Biology top 2%
- Protein Tyrosine Phosphatases 11
- Protein Kinase Regulation and GTPase Signaling 6
- Protein Degradation and Inhibitors 5
- PI3K/AKT/mTOR signaling in cancer 5
- Ubiquitin and proteasome pathways 4
- Cancer Research top 5%
- Oncology top 5%
- PARP inhibition in cancer therapy 3
- Co-authors
- Nicholas K. TonksAnnette SalmeenDavid BarfordMichael P. MyersLynda ChinP. Andrew FutrealJohn A. HinksTzu‐Ching Meng
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Jannik N. Andersen
33 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Immunology 1.4k
- Toxicology 177
- Molecular Biology 3.1k
- Cancer Research 423
- Oncology 575
Countries citing papers authored by Jannik N. Andersen
This map shows the geographic impact of Jannik N. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jannik N. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jannik N. Andersen more than expected).
Fields of papers citing papers by Jannik N. Andersen
This network shows the impact of papers produced by Jannik N. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jannik N. Andersen. The network helps show where Jannik N. Andersen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jannik N. Andersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2018 | 25 | |
| 5 | 2014 | 44 | |
| 6 | 2011 | 127 | |
| 7 | 2011 | 428 | |
| 8 | 2011 | 23 | |
| 9 | 2010 | 134 | |
| 10 | 2010 | 41 | |
| 11 | 2009 | 19 | |
| 12 | Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediatebreakdown → | 2003 | 780 |
| 13 | 2003 | 22 | |
| 14 | 2001 | 378 | |
| 15 | 2001 | 45 | |
| 16 | 2000 | 41 | |
| 17 | 2000 | 389 | |
| 18 | 1999 | 41 | |
| 19 | 1998 | 7 | |
| 20 | 1989 | 3 |
About Jannik N. Andersen
Jannik N. Andersen is a scholar working on Immunology, Molecular Biology and Toxicology, having authored 33 papers that have together received 3.8k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (11 papers), Galectins and Cancer Biology (11 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Protein Degradation and Inhibitors (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), interferon and immune responses (4 papers), Ubiquitin and proteasome pathways (4 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Immunology (1.4k citations), Toxicology (177 citations) and Molecular Biology (3.1k citations). Jannik N. Andersen has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Nicholas K. Tonks, Annette Salmeen, David Barford, Michael P. Myers, Lynda Chin, P. Andrew Futreal, John A. Hinks, Tzu‐Ching Meng, Ole Hartvig Mortensen and Peter Gildsig Jansen. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.